臨床試驗(yàn)設(shè)計(jì)的類型(1).pptx

Lea Drye, PhD,Johns Hopkins University,Types of Trial Design,Copyright 2013 Johns Hopkins University and Lea Drye. All Rights Reserved., Phase I: First stage in testing a new intervention in humans Usually 10-30 people Identify tolerable dose, provide information on drug metabolism, excretion, and toxicity Often not controlled Phase II: Usually 30-100 people Preliminary information on efficacy, additional information on safety and side effects Phase III: Usually 100+ people Assess efficacy and safety Controlled, usually randomized 2,Phases of trials,Lecture Outline, Discuss various trial design types Parallel Crossover Group allocation Factorial Large simple Equivalency Non-inferiority Adaptive,3,Comparison Structure: Parallel, Crossover, and Group,Allocation Designs,Section A,The material in this video is subject to the copyright of the owners of the material and is being provided for educational purposes under rules of fair use for registered students in this course only. No additional copies of the copyrighted work may be made or distributed.,Parallel Design, Simultaneous treatment and control groups Each person is randomly assigned to one treatment group Randomization removes treatment selection bias and promotes comparability of treatment groups Statistical comparisons made between treatment groups,|,P,叫,e G,巾,Randomized,占v,1，白,iJHSPH,Parallel Design Example: NETT,Source: NETT Research Group (1999). Chest 1999; 116: 1750-61; NETT Research Group (1999). J Thorac Cardiovasc Surg, 118: 518-528; Fishman, A., & Martinez, F., et al. (2003). N Engl J Med 348: 2059-73., National Emphysema Treatment Trial (NETT) - Phase III trial, unmasked,Parallel Design Example: NETT,Source: NETT Research Group (1999). Chest 1999; 116: 1750-61; NETT Research Group (1999). J Thorac Cardiovasc Surg, 118: 518-528; Fishman, A., & Martinez, F., et al. (2003). N Engl J Med 348: 2059-73.,Crossover Design, Randomization of order in which treatments are received AB or BA Randomization promotes balance between treatment groups in timing of exposure Testing of both treatments in each patient Each patient serves as his/her own control Variability reduced because less variability within patient than between patients Fewer patients needed,Crossover Design Graph,Washout,Group 1, Tx A,Group 1, Tx B,Group 2, Tx B,Group 2, Tx A,Crossover Design: Disadvantages, Treatment cant have permanent effects or cures Potential carry-over effects of first-period treatment to second period Washout needs to be long enough Unequal carry-over effects Treatment during washout Test for period by treatment interactions not powerful Dropouts more significant Analysis may be more difficult,Crossover Design: Uses, Constant intensity of underlying disease Chronic diseasesasthma, hypertension, arthritis Short-term treatment effects Relief of signs or symptoms of disease Metabolic, bioavailability, or tolerability studies,Crossover Design: Examples, Evening-dose vs. morning-dosed travoprost in open-angle glaucoma for 24-hour intraocular pressure control Montelukast vs. salmeterol as adjuvant to inhaled fluticasone for exercise-induced asthma in children Topical oil vs. placebo for neuropathic pain,Group Allocation Design, Also known as “cluster randomization” Randomization unit is a group of individuals (community, school, clinic) Individual randomization and intervention is not feasible or is unacceptable Tracking Contamination If there is a correlation in the responses within a group, design loses some efficiency (more individuals required),l,Ij川臼,Randomized,Group Allocation Example: Sommer Vit A trial,16,Lancet. 1986 May 24;1(8491):1169-73, Population Preschool children in northern Sumatra in 1982-83 Treatments Vitamin A supplementation during study Vitamin A supplementation after study Clusters Villages (450) selected using survey sampling method Each randomly allocated to one treatment,后面內(nèi)容直接刪除就行 資料可以編輯修改使用 資料可以編輯修改使用,主要經(jīng)營(yíng)：網(wǎng)絡(luò)軟件設(shè)計(jì)、圖文設(shè)計(jì)制作、發(fā)布廣告等 公司秉著以優(yōu)質(zhì)的服務(wù)對(duì)待每一位客